By Marta Banuelos, Smarta Functional Medicine
Hashimoto’s is an autoimmune condition that gradually damages the thyroid, often causing low thyroid hormone levels and symptoms like fatigue, weight gain, and mood changes. Looking at genetics first gives clinicians a clearer picture of what may be driving each patient’s disease, so care can be tailored rather than borrowed from a one-size-fits-all playbook. In this review, we explain how genetic insights are used at Smarta Functional Medicine to sharpen diagnosis and craft personalized treatment plans. We’ll cover the role genetics play in autoimmune thyroid disease, how testing works, and how those results inform root-cause consultations and targeted therapies compared with conventional care.
Hashimoto’s is a long-term autoimmune disorder in which the immune system attacks the thyroid, reducing hormone production. Symptoms vary but commonly include weight gain, profound tiredness, and thinning hair. Prioritizing genetics helps reveal inherited risk markers that affect disease course and treatment response. A genetics-first perspective uncovers patterns that can explain why some people don’t respond to standard approaches and where more personalized strategies may help.
Research increasingly shows that autoimmune thyroid disorders arise from a complex mix of inherited and environmental influences.
Genetic and Environmental Factors in Autoimmune Thyroid Disease
Summary: Autoimmune thyroid diseases like Graves’ and Hashimoto’s develop from layered interactions between genes and the environment. Understanding genetic susceptibility helps map who’s at risk and how that risk may change over time. (Genetic susceptibility to autoimmune thyroid disease: past, present, and future, 2010)
Inherited genetic differences meaningfully affect how autoimmune thyroid conditions develop and how patients respond to treatment. Variants in genes such as DIO2 and certain HLA alleles are linked to disease risk and therapeutic outcomes. Knowing a patient’s genetic profile lets clinicians tailor interventions to metabolic tendencies and immune behavior, making treatments more precise and often more effective.
Ongoing research continues to clarify the complex genetic architecture of Hashimoto’s, including rare monogenic contributors.
Genetic Complexity and Environmental Factors in Hashimoto's Thyroiditis
Summary: Recent genetic work has started to quantify heritability and reveal the layered genetic factors involved in Hashimoto’s, while also highlighting environmental contributors, including drugs that affect immune function. (An update on the pathogenesis of Hashimoto’s thyroiditis, A.P. Weetman, 2021)
Genetic testing refines diagnosis by identifying markers tied to autoimmune thyroid disease and related metabolic pathways. These results help clinicians estimate individual risk, predict likely treatment responses, and shape both immediate and long-term management plans. At Smarta Functional Medicine, genetic data adds a new layer of clarity to clinical decision-making, enabling more focused hormone strategies and prevention-minded care.
Multiple gene polymorphisms have been linked to increased susceptibility for autoimmune thyroid disease, reinforcing the role of genetics in disease development.
Genetic Susceptibility and Gene Polymorphisms in Autoimmune Thyroid Disease
Summary: Studies have confirmed that variants in several genes—HLA-DR alleles and genes encoding CTLA-4, PTPN22, FCRL3, and likely IL-2 receptor components—lower the threshold for autoimmunity. Other genes and environmental factors help determine why the thyroid becomes the primary target. (The genetics of autoimmune thyroid disease, A.P. Weetman, 2009)
The genetic testing process for Hashimoto’s generally follows these steps:
This stepwise approach ensures genetic information is used practically to guide care rather than as abstract data.
Genetic test results become a foundation for individualized treatment plans. At Smarta Functional Medicine, we use genetic insights to tailor nutrition, supplement choices, and lifestyle interventions to a patient’s specific metabolic and immune profile. That makes treatments more targeted—aimed at the drivers of dysfunction rather than only masking symptoms—so patients often see better, more sustainable results.
Root-cause consultations focus on uncovering the biological and lifestyle factors contributing to Hashimoto’s and hypothyroidism rather than only treating symptoms. That means a deep-dive assessment of diet, sleep, stress, exposures, and genetics. Functional medicine treatments then combine targeted nutrition, specific supplements, and lifestyle prescriptions designed to support thyroid function and rebalance the immune system based on each patient’s needs.
In a root-cause consultation at Smarta Functional Medicine, expect a thorough, collaborative evaluation that covers:
Our goal is to engage and empower you with a clear, actionable plan for recovery and long-term health.
Functional medicine supports thyroid health through focused, evidence-informed strategies that help the body heal and regulate itself:
These interventions aim to improve thyroid function and overall wellbeing, often reducing symptom burden and improving quality of life.
A genetics-first functional medicine model offers several advantages compared with conventional care. Rather than relying on standardized protocols, this approach uses genetic information to shape individualized plans. Key benefits include:
With this approach, patients become active partners in a proactive, precision-focused care plan.
Genetics-first care differs from standard hormone replacement by emphasizing individualized understanding over symptom-only management. While hormone replacement focuses on correcting low hormone levels, a genetics-informed protocol:
This model aims to combine the benefits of symptom relief with strategies that support lasting health.
There is growing evidence that personalized, functional-medicine approaches can benefit people with Hashimoto’s. Clinical reports and studies show improvements in thyroid markers, symptom burden, and quality of life when care targets root causes and individual needs. Key observations include:
These outcomes support functional medicine as a practical option for people seeking a personalized path to better thyroid health.
Taking a genetics-first approach to Hashimoto’s enables truly personalized treatment plans that aim at underlying causes. By combining genetic insights with comprehensive clinical evaluation, Smarta Functional Medicine designs interventions that improve symptoms and support long-term thyroid health. If you’re ready to explore a more individualized path, learn more about our programs and how we help patients reclaim their well-being.
Smarta Functional Medicine, led by Marta Banuelos, takes a genetics-first approach to treating women with Hashimoto’s thyroiditis. Marta combines functional medicine and clinical genetics to uncover the root causes of symptoms that traditional medicine often overlooks. She focuses on personalized care, mapping an individual's DNA to create a unique treatment plan that addresses thyroid hormone conversion, immune system regulation, and nutrient absorption. Patients undergo a comprehensive genetic test, known as the Hashimoto’s Genetic Blueprint, which analyzes over 134 genes to provide a clear understanding of each patient's unique biology. This method is particularly tailored to Hashimoto's patients who have not seen improvement with standard protocols. Key services include a root cause consultation, the Hashimoto’s Genetic Blueprint test, and personalized care plans based on genetic results. Marta offers both one-on-one and group programs that are meticulously designed according to each patient's specific needs and genetic makeup. Her approach ensures that treatments move beyond general advice to actual solutions based on scientific insight. What sets Smarta Functional Medicine apart is the focus on deeper understanding and individualized care. By using advanced genetic testing and comprehensive assessments, Marta offers patients a way to truly understand their condition. This practice eschews generic protocols, focusing on precise, scientifically grounded treatments. It aims to empower patients with knowledge about their condition, working against the conventional narrative of 'normal labs,' which often misleads patients with far-reaching health issues. The practice is fully virtual, allowing Marta to reach patients throughout most U.S. states.